4//SEC Filing
Zynerba Pharmaceuticals, Inc. 4
Accession 0001123292-17-001119
CIK 0001621443operating
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:11 PM ET
Size
5.3 KB
Accession
0001123292-17-001119
Insider Transaction Report
Form 4
COOPER WARREN D
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-07+15,000→ 15,000 totalExercise: $18.77Exp: 2027-06-07→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of (i) June 7, 2018 and (ii) the day before the 2018 annual meeting of stockholders of Zynerba Pharmaceuticals, Inc.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001621443
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:11 PM ET
- Size
- 5.3 KB